M&A Deal Summary

Clarient Acquires Applied Genomics

On December 21, 2009, Clarient acquired life science company Applied Genomics from Greer Capital Advisors for 18M USD

Acquisition Highlights
  • This is Clarient’s 1st transaction in the Life Science sector.
  • This is Clarient’s largest (disclosed) transaction.
  • This is Clarient’s 1st transaction in the United States.
  • This is Clarient’s 1st transaction in Alabama.

M&A Deal Summary
Date 2009-12-21
Target Applied Genomics
Sector Life Science
Buyer(s) Clarient
Sellers(s) Greer Capital Advisors
Deal Type Add-on Acquisition
Deal Value 18M USD
Advisor(s) Aquilo Partners LP (Financial)
Balch & Bingham (Legal)

Target

Applied Genomics

Huntsville, Alabama, United States
Applied Genomics, Inc. develops targeted genomics-based diagnostic and therapeutic antibodies for the treatment of cancer.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Clarient

Aliso Viejo, California, United States
Category Company
Founded 1993
Sector Healthcare Services
Employees415
Revenue 92M USD (2009)
DESCRIPTION

Clarient, Inc. is a provider of comprehensive cancer diagnostic testing to hospitals and physicians in the pharmaceutical industry.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Alabama) 1 of 1
Country (United States) 1 of 1
Year (2009) 1 of 1
Size (of disclosed) 1 of 1

Seller(S) 1

SELLER

Greer Capital Advisors

Mountain Brook, Alabama, United States

Investor

Category Private Equity Firm
Founded 2002
Size Small
Type Sector Focused
DESCRIPTION

Greer Capital Advisors (GCA) is a specialized, heathcare focused private equity firm that targets investments in Alabama based companies. Within healthcare, GCA looks for companies in the pharmaceutical, biotechnology, medical device, and diagnostics industries. GCA prefers early and growth stage investments and generally seeks to invest between $1 to $2 million per transaction. Greer Capital Advisors was formed in 2002 and is based in Birmingham, Alabama.

DEAL STATS #
Overall 4 of 13
Sector (Life Science) 3 of 10
Type (Add-on Acquisition) 3 of 10
State (Alabama) 1 of 7
Country (United States) 4 of 13
Year (2009) 1 of 1
Size (of disclosed) 5 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-12-18 CardioSpectra

San Antonio, Texas, United States

CardioSpectra, Inc. is a medical device company committed to developing novel solutions for worldwide healthcare problems through the implementation of its expertise in optical imaging, interventional cardiology, medical devices, and materials science.

Sell $25M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-10-08 BioDtech

Birmingham, Alabama, United States

BioDtech, Inc. develops and markets products for the detection, neutralization, and removal of biological toxins for pharmaceutical manufacturing and clinical applications. BioDtech was founded in 2003 and is based in Birmingham, Alabama.

Buy -
Mergr

Product

Company

Legal